THE CONSTRUCT (RESIDUES 24-405) WAS EXPRESSED WITH A PURIFICATION TAG MGSDKIHHHHHHENLYFQG. THE TAG ...THE CONSTRUCT (RESIDUES 24-405) WAS EXPRESSED WITH A PURIFICATION TAG MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE.
-
実験情報
-
実験
実験
手法: X線回折 / 使用した結晶の数: 1
-
試料調製
結晶
マシュー密度: 3.03 Å3/Da / 溶媒含有率: 59.37 % 解説: DATA WERE SCALED USING XSCALE WITH FRIEDEL PAIRS KEPT AS SEPARATE WHEN COMPUTING R-SYM, COMPLETENESS AND
結晶化
温度: 293 K / 手法: 蒸気拡散法, シッティングドロップ法 / pH: 7.2 詳細: 20.00% polyethylene glycol 3350, 0.2000M potassium sodium tartrate, No Buffer pH 7.2, Additive: 0.001 M zinc chloride, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 293K
モノクロメーター: DOUBLE CRYSTAL SI (111) / プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray
放射波長
波長: 0.97898 Å / 相対比: 1
反射
解像度: 2.23→29.966 Å / Num. obs: 154800 / % possible obs: 98.7 % / Observed criterion σ(I): -3 / Biso Wilson estimate: 38.695 Å2 / Rmerge(I) obs: 0.073 / Net I/σ(I): 13.23
反射 シェル
解像度 (Å)
Rmerge(I) obs
Mean I/σ(I) obs
Num. measured obs
Num. unique obs
Diffraction-ID
% possible all
2.23-2.31
0.534
2.6
115688
30326
1
99.6
2.31-2.4
0.429
3.2
113399
29527
1
99.6
2.4-2.51
0.335
4.1
117785
30569
1
99.5
2.51-2.64
0.254
5.3
115045
29818
1
99.5
2.64-2.81
0.177
7.4
119727
31005
1
99.3
2.81-3.02
0.121
10.4
112345
29172
1
98.9
3.02-3.33
0.076
15.7
118074
30717
1
98.7
3.33-3.81
0.048
22.8
114440
29826
1
98.3
3.81-4.78
0.035
29.1
112755
29403
1
97.7
4.78-29.966
0.031
32.5
114028
29501
1
95.5
-
位相決定
位相決定
手法: 単波長異常分散
-
解析
ソフトウェア
名称
バージョン
分類
NB
SHELX
位相決定
REFMAC
5.6.0093
精密化
XSCALE
データスケーリング
PDB_EXTRACT
3.1
データ抽出
XDS
データ削減
SHELXD
位相決定
autoSHARP
位相決定
精密化
構造決定の手法: 単波長異常分散 / 解像度: 2.23→29.966 Å / Cor.coef. Fo:Fc: 0.963 / Cor.coef. Fo:Fc free: 0.953 / Occupancy max: 1 / Occupancy min: 0.22 / SU B: 7.033 / SU ML: 0.094 / 交差検証法: THROUGHOUT / σ(F): 0 / ESU R: 0.192 / ESU R Free: 0.15 立体化学のターゲット値: MAXIMUM LIKELIHOOD WITH PHASES 詳細: 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. 2. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY OF THE SE ATOMS IN THE ...詳細: 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. 2. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET INCORPORATION. 3. ATOM RECORD CONTAINS SUM OF TLS AND RESIDUAL B FACTORS. ANISOU RECORD CONTAINS SUM OF TLS AND RESIDUAL U FACTORS. 4. WATERS WERE EXCLUDED FROM AUTOMATIC TLS ASSIGNMENT. 5. ZINC, POTASSIUM, CHLORIDE, ACETATE (ACT), AND ETHYLENE GLYCOL(EDO) MODELED ARE PRESENT PROTEIN/CRYSTALLIZATION /CRYO BUFFER. 6. NCS RESTRAINTS WERE APPLIED USING REFMAC IMPLEMENTATION OF LOCAL NCS RESTRAINTS (NCS LOCAL).
Rfactor
反射数
%反射
Selection details
Rfree
0.1812
7771
5 %
RANDOM
Rwork
0.1592
-
-
-
obs
0.1603
154749
98.36 %
-
溶媒の処理
イオンプローブ半径: 0.8 Å / 減衰半径: 0.8 Å / VDWプローブ半径: 1.2 Å / 溶媒モデル: MASK